Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center

Von Ariva.deFebruar 2, 20266 Kommentare10.3k Aufrufe

Listen to the article

0:00

Kernaussagen

🌐 Translate Article

Translating...

📖 Read Along

💬 AI Assistant

🤖

Hi! I'm here to help you understand this article. Ask me anything about the content!

OMER, Israel, Feb. 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the United States, following receipt of FDA approval for its home pregnancy ultrasound product.

At the end of January 2026, the Company (through its subsidiary) entered into a services agreement with the Center for Fetal Medicine & Women’s Ultrasound, a fetal medicine and women’s ultrasound center located in LA California (the „CFFM“).

Den vollständigen Artikel hier lesen

Ariva.de

Ariva.de ist ein deutsches Börsen- und Finanzportal mit Kursdaten, Nachrichten und Analysen rund um Aktien, Indizes, Rohstoffe und Kryptowährungen. Zusätzlich bietet die Plattform eine aktive Community mit Diskussionen und Marktkommentaren zu aktuellen Finanzthemen.

6 Kommentare

Lea F. Schäfer am Februar 2, 2026 3:33 p.m.

Solid analysis. Will be watching this space.

Antworten
Karl Müller am Februar 2, 2026 3:36 p.m.

I’ve been following this closely. Good to see the latest updates.

Antworten
- Karl Meyer am Februar 2, 2026 4:14 p.m.
  
  Good point. Watching closely.
  
  Antworten
Anna Müller am Februar 2, 2026 3:38 p.m.

Great insights on Fonds-News. Thanks for sharing!

Antworten
Emma Wagner am Februar 2, 2026 3:38 p.m.

This is very helpful information. Appreciate the detailed analysis.

Antworten
Mia Weber am Februar 2, 2026 3:40 p.m.

Interesting update on Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center. Looking forward to seeing how this develops.

Antworten